JW (Cayman) Therapeutics Co. Ltd 藥明巨諾(開曼)有限公司* (於開曼群島註冊成立的有限公司) (股份代號:2126) 自願公告 業務更新 國家藥品監督管理局接受倍諾達®治 療 復發或難治性細胞淋巴瘤患者的補充生物製品許可申請 JW (Cayman) Therapeutics Co. Ltd(藥明巨諾(開曼)有限公司*)(「本公司」 或「藥明...
JW (Cayman) Therapeutics Co. Ltd * (Incorporated in the Cayman Islands with limited liability) Stock Code: 2126 Annual Report * Contents 2 Corporate Information 4 Chairman's Statement 7 Financial Highlights 11 Business Highlights 14 Management Discussion and Analysis 41 Directors and Senior Management...
简介:JW (Cayman) Therapeutics Co. Ltd,成立于2020年,位于香港特别行政区。 展开 项目品牌:JW Therapeutics 融资历程0竞品数量21 企业全景 瞬息掌握企业关系 天眼图谱 登记信息 发生变更时通知我 自身风险 0条该公司暂无自身风险信息 周边风险 0条该公司暂无周边风险信息 ...
JW (Cayman) Therapeutics Co Ltd is a company primarily engaged in research and development, manufacturing, and marketing of cellular immunotherapy products. The Company has built an integrated platform for product development in cell immunotherapy, as well as a product pipeline covering hematologic malig...
JW (Cayman) Therapeutics Co. Ltd 藥明巨諾(開曼)有限公司* (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立的有限公司) GLOBAL OFFERING 全球發售 Number of Offer Shares under the Global Offering : 97,692,000 Shares (subject to the Over-allotment Option) 全球發售的...
所属公司:JW (Cayman) Therapeutics Co. Ltd 成立日期:0000-00-00 简介:JW (Cayman) Therapeutics Co. Ltd是全球领先的临床阶段细胞治疗平台公司。其旨为中国癌症患者带来革命性的新兴治疗方式。其主打候选产品Relmacabtagene autoleucel(「relma-cel」)是针对复发或难治(「r/r」)B细胞淋巴瘤的抗CD19 CAR-T...
JW (Cayman) Therapeutics Co Ltd is a company primarily engaged in research and development, manufacturing, and marketing of cellular immunotherapy products. The Company has built an integrated platform for product development in cell immunotherapy, as well as a product pipeline covering hematologic malig...
Sep JW Therapeutics (Suzhou) Co., Ltd. founded Nov Started world-leading commercial scale cell therapy manufacturing project Dec JW Therapeutics R&D center opened 2019 Feb Recognized as a “Foreign-invested R&D center” by Shanghai Municipal People’s Government Dec Completed cell therapy commercia...
JW (Cayman) Therapeutics Co. Ltd 藥明巨諾(開曼)有限公司* (「本公司」) (於開曼群島註冊成立的有限公司) (股份代號:2126) 定義 審核委員會職權範圍 1. 就本職權 範圍(「職權範圍」)而言 : 審核委員會指董事會根據本職權範圍第2條通過的決議案而設立的審核委 員會. 董事會指本公司的董事會. 首席財務...
JW (Cayman) Therapeutics Co. Ltd 藥明巨諾(開曼)有限公司* (「本公司」) (於開曼群島註冊成立的有限公司) (股份代號:2126) 定義 提名委員會職權範圍 1. 就本職權 範圍(「職權範圍」)而言 : 董事會指本公司的董事會. 首席財務官指董事會不時委任負責管理財務的本公司高級行政人員. 公司秘書指本公司的公司...